6 results match your criteria: "Hospital University Pharmacotoxicology Department[Affiliation]"
Acta Psychiatr Scand
November 2024
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy, Berlin, Germany.
Objective: In recent years, safety concerns about modafinil exposure during pregnancy have emerged. In particular, increased risks for major congenital anomalies (MCA) and impaired fetal growth were reported, although study results were conflicting. Our investigation aims to examine previously reported safety signals.
View Article and Find Full Text PDFTherapie
November 2023
Department of Infectious and Tropical Diseases, Croix Rousse Hospital, Hospices Civils de Lyon, 69003 Lyon, France.
J Eur Acad Dermatol Venereol
April 2023
Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil, France.
Therapie
May 2023
Pharmacovigilance Center, Hospital University Pharmacotoxicology Department, Hospices civils de Lyon, 69003 Lyon, France. Electronic address:
The association between vaccines and peripheral facial palsy (PFP), an issue that has been the subject of debate for many years, has been raised again following results of clinical trials assessing mRNA based COVID-19 vaccines. To review the available literature on this topic, PubMed was searched from inception until February 25, 2022. Inclusion criteria were case reports with documented rechallenge and comparative epidemiological studies.
View Article and Find Full Text PDFClin Drug Investig
July 2022
Pharmacovigilance Center, Hospital University Pharmacotoxicology Department, Hospices civils de Lyon, 162 avenue Lacassagne, 69003, Lyon, France.
Background And Objective: The concern surrounding the association between Guillain-Barré syndrome (GBS) and vaccination has increased with the widespread use of COVID-19 vaccines. The aim of this study was to assess the potential association of GBS with mRNA-based or adenovirus-vectored COVID-19 vaccines.
Methods: Reports of GBS associated with mRNA-based or adenovirus-vectored COVID-19 vaccines were extracted from the WHO pharmacovigilance database, exposure data from the Our World in Data website, and the background rates of GBS from published data.
Blood
April 2022
Department of Medical Pharmacology, Centre of Pharmacovigilance, Bordeaux University Hospital, Bordeaux, France; and.